Switch to:

Beam Therapeutics Short-Term Capital Lease Obligation

: $4.70 Mil (As of Mar. 2020)
View and export this data going back to 2020. Start your Free Trial

Beam Therapeutics's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2020 was $4.70 Mil.

Beam Therapeutics's quarterly Short-Term Capital Lease Obligation increased from Sep. 2019 ($2.75 Mil) to Dec. 2019 ($4.34 Mil) and increased from Dec. 2019 ($4.34 Mil) to Mar. 2020 ($4.70 Mil).

Beam Therapeutics's annual Short-Term Capital Lease Obligation stayed the same from Dec. 2017 ($0.00 Mil) to Dec. 2018 ($0.00 Mil) but then increased from Dec. 2018 ($0.00 Mil) to Dec. 2019 ($4.34 Mil).


Beam Therapeutics Short-Term Capital Lease Obligation Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Beam Therapeutics Annual Data
Dec17 Dec18 Dec19
Short-Term Capital Lease Obligation 0.00 0.00 4.34

Beam Therapeutics Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Short-Term Capital Lease Obligation Premium Member Only Premium Member Only 0.00 1.96 2.75 4.34 4.70

Beam Therapeutics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


Beam Therapeutics Short-Term Capital Lease Obligation Related Terms


Beam Therapeutics Short-Term Capital Lease Obligation Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)